Thumb Arthritis Treatment Market Growth, Analysis, Business Opportunities and Latest Innovations 2027

In thumb arthritis, the cushion-like cartilage inside the CMC joint breaks down, causing the bones to rub against each other. Increasing prevalence of basal thumb arthritis market, growing geriatric and obese population, and rising healthcare expenditure are some of the major factors estimated to drive the market growth during the forecast period.

The Global Thumb Arthritis Market is expected to grow at an approximate CAGR of 8.1% during the forecast period. A study was published in the HAND (American Association for Hand Surgery) journal in 2016, according to which the prevalence of the thumb CMC osteoarthritis was estimated to be around 8%-12% in the general population. However, the high cost of the surgical therapeutics along with related complications is estimated to restrain the market growth during the forecast period.

Get Sample Copy of Report @ 


The global thumb arthritis market is segmented based on type, diagnosis, treatment, and end user.

By Type

  • Osteoarthritis Thumb Arthritis
  • Rheumatoid Thumb Arthritis
  • Others

By Diagnosis

  • Physical Examinations
  • Imaging
  • Fine Needle Aspiration (FNA)
  • Others

By Treatment

  • Thumb Exercise
  • Medication
  • Surgery
  • Others

By End users

  • Hospitals & Clinics
  • Research Organizations
  • Retail Pharmacies
  • Others

Key Players

The key players in the global thumb arthritis test market are inclusive of

  • BioPro (U.S.)
  • McKie Splints (U.S.)
  • AbbVie Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Amgen Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Carestream Health. (U.S.)
  • General Electric Company (U.K)
  • Others

Regional Analysis

The Americas dominate the global thumb arthritis market. A well-developed healthcare sector, growing geriatric population, and increasing healthcare expenditure are the major drivers for the growth of the global thumb arthritis market.

Europe holds the second largest thumb arthritis market owing to the availability of the funds for research, increasing surgery adoption rates, and growing patient population. According to the Office for National Statistics the geriatric population within the region is expected to grow and reach 20.5% of the total U.K population by 2026 from 18.0% in 2016.

Asia Pacific is the fastest growing region. Growing geriatric and obese population followed by the developing healthcare sector are boosting the market growth. Within the region, Australia holds a significant ratio of the obese population. However, the presence of the developing economies like India and China are marked by expanding healthcare sector. This is estimated to provide favorable backgrounds for the market growth.

Get Access Full Report @ 

The Middle East and Africa region account for the least market share. This is mainly due to the presence of the poor African economies within the region, which have low per capita income and lack of the medical services. On the other, the Middle East holds the largest market share within the region.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York, New York 10013,

United States of America

+1 646 845 9312


Comments are closed